Benzimidazole: An emerging scaffold for analgesic and anti-inflammatory agents

European Journal of Medicinal Chemistry

Volumn 76, Issue , 2014, Pages 494-505

  Gaba, Monika ^a   Singh, Sarbjot ^b   Mohan, Chander ^c  

^a Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy   (India)

^b Panacea Biotec Pvt Ltd   (India)

^c Rayat Bahra Institute of Pharmacy   (India)

Author keywords

Analgesic; Benzimidazole; Cyclooxygenase 2 (COX 2) inhibitors; Non steroidal anti inflammatory drugs (NSAIDs)

Indexed keywords

ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN INHIBITOR; BENZIMIDAZOLE DERIVATIVE; BRADYKININ ANTAGONIST; CANNABINOID RECEPTOR AGONIST; CYCLOOXYGENASE 2 INHIBITOR;

ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; BIOLOGICAL ACTIVITY; DRUG DEVELOPMENT; DRUG TARGETING; HUMAN; INFLAMMATION; PAIN; PHARMACOPHORE; REVIEW; CHEMISTRY;

ANALGESICS; ANTI-INFLAMMATORY AGENTS; BENZIMIDAZOLES; DRUG DISCOVERY; HUMANS; INFLAMMATION; PAIN;

EID: 84895895067     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2014.01.030     Document Type: Short Survey

References (74)

1. J.B. Wright The chemistry of the benzimidazoles Chem. Rev. 48 3 1951 397 541
2. H.A. Barker, R.D. Smyth, H. Weissbach, J.I. Toohey, J.N. Ladd, and B.E. Volcani Isolation and properties of crystalline cobamide coenzymes containing benzimidazole or 5,6 dimethylbenzimidazole J. Biol. Chem. 235 2 1960 480 488
3. A.A. Spasov, I.N. Yozhitsa, L.I. Bugaeva, and V.A. Anisimova Benzimidazole derivatives: spectrum of pharmacological activity and toxicological properties Pharm. Chem. J. 33 5 1999 232 243
4. S.L. Khokra, and D. Choudhary Benzimidazole an important scaffold in drug discovery Asian J. Biochem. Pharm. Res. 3 1 2011 476 486
5. V.K. Vyas, and M. Ghate Substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonist: a review Mini-Rev. Med. Chem. 10 14 2010 1366 1384
6. T. Edwards Inflammation, pain, and chronic disease: an integrative approach to treatment and prevention Altern. Ther. Health Med. 11 6 2005 20 27 (Pubitemid 43885298)
7. D.J. Gaskin, and P. Richard The economic costs of pain in the United States J. Pain 13 8 2012 715 724
8. http://www.thepharmaletter.com/file/108598/anti-inflammatory- therapeutics-market-to-grow-to859-billion-in-2017.htm
9. M.R. Shaaban, T.S. Saleh, A.S. Mayhoub, A. Mansour, and A.M. Farag Synthesis and analgesic/anti-inflammatory evaluation of fused heterocyclic ring systems incorporating phenylsulfonyl moiety Bioorg. Med. Chem. 16 12 2008 6344 6352 (Pubitemid 351783421)
10. M.S. Bergh, and S.C. Budsberg The coxib NSAIDs: potential clinical and pharmacologic importance in veterinary medicine J. Vet. Intern. Med. 19 5 2005 633 643 (Pubitemid 41452333)
11. B. Feldman, J. Zinkl, and N. Jain Veterinary Hematology fifth ed. 2000 Lippincott Williams and Wilkins Philadelphia, PA 213
12. L.A. Trepanier Mechanisms of drug-associated hepatotoxicity in the dog and cat Proceedings of the 20th annual forum of the ACVIM, Dallas 2002 669 671
13. I.L. Meek, M.A.F.J. Van de Laar, and H.E. Vonkeman Non-steroidal anti-inflammatory drugs: an overview of cardiovascular risks Pharmaceuticals 3 2010 2146 2162
14. S.X. Sun, K.Y. Lee, C.T. Bertram, and J.L. Goldstein Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilization Curr. Med. Res. Opin. 23 8 2007 1859 1866 (Pubitemid 47300385)
15. C.A. Dinarello Anti-inflammatory agents: present and future Cell 140 6 2010 935 950
16. R.G. Ingle, and D.D. Magar Heterocyclic chemistry of benzimidazoles and potential activities of derivatives Int. J. Drug. Res. Technol. 1 1 2011 26 32
17. H. Walba, and R.W. Isensee Acidity constants of some arylimidazoles and their cations J. Org. Chem. 26 1961 2789 2791
18. J.R. Vane Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs Nat. New Biol. 231 1971 232 235
19. J.B. Smith, and A.L. Willis Aspirin selectively inhibits prostaglandin production in human platelets Nat. New Biol. 231 1971 235 237
20. W.L. Xie, J.G. Chipman, D.L. Robertson, R.L. Erikson, and D.L. Simmons Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing Proc. Natl. Acad. Sci. U.S.A. 88 1991 2692 2696 (Pubitemid 21916484)
21. D.A. Kubuju, B.S. Fletcher, B.C. Varnum, R.A. Lim, and H.R. Herschman TIS10, a phorbol ester tumor promoter/inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue J. Biol. Chem. 266 1991 12866 12872
22. T. Hla, and K. Neilson Human cyclooxygenase-2 cDNA Proc. Natl. Acad. Sci. U.S.A. 89 1992 7384 7388
23. H.R. Herschman Prostaglandin synthase 2 Biochim. Biophys. Acta 1299 1 1996 125 140 (Pubitemid 26007741)
24. R. Paramashivappa, P.P. Kumar, P.V.S. Rao, and A.S. Rao Design, synthesis and biological evaluation of benzimidazole/benzothiazole and benzoxazole derivatives as cyclooxygenase inhibitors Bioorg. Med. Chem. Lett. 13 4 2003 657 660 (Pubitemid 36298462)
25. C.J. Smith, Y. Zhang, C.M. Koboldt, J. Muhammad, B.S. Zweifel, A. Shaffer, J.J. Talley, J.L. Masferrer, K. Seibert, and P.C. Isakson Pharmacological analysis of cyclooxygenase-1 in inflammation Proc. Natl. Acad. Sci. U.S.A. 95 1998 13313 13318 (Pubitemid 28509568)
26. I. Nagy, P. Santha, G. Jancso, and L. Urban The role of the vanilloid (capsaicin) receptor (TRPV1) in physiology and pathology Eur. J. Pharmacol. 500 1-3 2004 351 369 (Pubitemid 39304020)
27. D. Smart, M.J. Gunthrope, J.C. Jerman, S. Nasir, J. Gray, A.I. Muir, J.K. Chambers, A.D. Randal, and J.B. Davis The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1) Br. J. Pharm. 129 2 2000 227 230 (Pubitemid 30072640)
28. S.W. Hwang, H. Cho, J. Kwak, S.Y. Lee, C.J. Kang, J. Jung, S. Cho, K.H. Min, Y.G. Suh, D. Kim, and U. Oh Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances Proc. Natl. Acad. Sci. U.S.A. 97 2000 6155 6160 (Pubitemid 30367539)
29. M.J. Caterina, and D. Julius The vanilloid receptor: a molecular gateway to the pain pathway Annu. Rev. Neurosci. 24 2001 487 517 (Pubitemid 32695237)
30. A. Szallasi, and G. Appendino Vanilloid receptor TRPV1 antagonists as the next generation of painkillers. Are we putting the cart before the horse J. Med. Chem. 47 11 2004 2717 2723 (Pubitemid 38656724)
31. K.J. Valenzano, and Q. Sun Current perspectives on the therapeutic utility of VR1 antagonists Curr. Med. Chem. 11 2004 3185 3202 (Pubitemid 39534745)
32. H.K. Rami, and M.J. Gunthorpe The therapeutic potential of TRPV1 (VR1) antagonists: clinical answers await Drug Discov. Today: Ther. Strateg. 1 2004 97 104 (Pubitemid 40208014)
33. M.L. Lopez-Rodriguez, A. Viso, and S. Ortega-Gutierrez VR1 receptor modulators as potential drugs for neuropathic pain Mini-Rev. Med. Chem. 3 7 2003 729 748
34. V.I. Ognyanov, C. Balan, A.W. Bannon, Y. Bo, C. Dominguez, C. Fotsch, V.K. Gore, L. Klionsky, V.V. Ma, Y.X. Qian, R. Tamir, X. Wang, N. Xi, S. Xu, D. Zhu, N.R. Gavva, J.J. Treanor, and M.H. Norman Design of potent, orally available antagonists of the transient receptor potential vanilloid 1. Structure-activity relationships of 2-piperazin-1-yl-1H benzimidazoles J. Med. Chem. 49 12 2006 3719 3742 (Pubitemid 43902478)
35. S.R. Fletcher, E. McIver, S. Lewis, F. Burkamp, C. Leech, G. Mason, S. Boyce, D. Morrison, G. Richards, K. Sutton, and A.B. Jones The search for novel TRPV1-antagonists: from carboxamides to benzimidazoles and indazolones Bioorg. Med. Chem. Lett. 16 2006 2872 2876 (Pubitemid 44316655)
36. Y. Cheng, and S.A. Hitchcock Targeting cannabinoid agonists for inflammatory and neuropathic pain Expert Opin. Invest. Drugs 16 7 2007 951 965 (Pubitemid 47074154)
37. C. Watson, D.R. Owen, D. Harding, K. Kon-I, M.L. Lewis, H.J. Mason, M. Matsumizu, T. Mukaiyama, M. Rodriguez-Lens, A. Shima, M. Takeuchi, I. Tran, and T. Young Optimisation of a novel series of selective CNS penetrant CB2 agonists Bioorg. Med. Chem. Lett. 21 2011 4284 4287
38. H.J.M. Gijsen, M.A.J. De Cleyn, M. Surkyn, G.R.E. Van Lommen, B.M.P. Verbist, M.J.M.A. Nijsen, T. Meert, J.V. Wauwe, and J. Aerssens 5-Sulfonyl-benzimidazoles as selective CB2 agonists-Part 2 Bioorg. Med. Chem. Lett. 22 2012 547 552
39. D.J. Campbell The kallikrein-kinin system in humans Clin. Exp. Pharmacol. Physiol. 28 12 2001 1060 1065 (Pubitemid 34053524)
40. E.G. Erdos Kinins, the long march-a personal view Cardiovasc. Res. 54 3 2002 485 491 (Pubitemid 34595405)
41. F. Marceau, J.F. Hess, and D.R. Bachvarov The B1 receptors for kinins Pharmacol. Rev. 50 3 1998 357 386
42. D. Regoli, and J. Barabe Pharmacology of bradykinin and related kinins Pharmacol. Rev. 32 1 1980 1 46
43. 1 receptor antagonists Bioorg. Med. Chem. Lett. 18 2008 5027 5031
44. G. Zischinsky, R. Stragies, M. Schaudt, J.R. Pfeifer, C. Gibson, E. Locardi, D. Scharn, U. Richter, H. Kalkhof, K. Dinkel, and K. Schnatbaum Novel small molecule bradykinin B1 receptor antagonists. Part 2: 5-membered diaminoheterocycles Bioorg. Med. Chem. Lett. 20 2010 1229 1232
45. A. Tincani, L. Andreoli, C. Bazzani, D. Bosiso, and S. Sozzani Inflammatory molecules: a target for treatment of systemic autoimmune diseases Autoimmun. Rev. 7 1 2007 1 7 (Pubitemid 47633384)
46. Y. Hu, N. Gren, L.K. Gavrin, K. Janz, N. Kaila, and H.Q. Li Inhibition of Tpl2 kinase and TNFα production with quinoline-3-carbonitriles for the treatment of rheumatoid arthritis Bioorg. Med. Chem. Lett. 16 2006 6067 6072 (Pubitemid 44667801)
47. J.C. Lee, J.T. Laydon, P.C. McDonnell, T.F. Gallagher, S. Kumar, and D.A. Green Protein kinase involved in the regulation of inflammatory cytokine biosynthesis Nature 372 2002 739 746
48. 2 by 38-kDa mitogen-activated protein kinase in collagen-stimulated human platelets Eur. J. Biochem. 245 1997 751 759 (Pubitemid 27223910)
49. A.D. Dios, C.B. Shih, L.D. Uralde, C. Sanchez, M.D. Prado, and M.M. Cabrejas Design of potent and selective 2-aminobenzimidazole-based p38α MAP kinase inhibitors with excellent in vivo efficacy J. Med. Chem. 48 2005 2270 2273 (Pubitemid 40516420)
50. M. Sabat, J.C. VanRens, M.J. Laufersweiler, T.A. Brugel, J. Maier, A. Golebiowski, B. De, V. Easwaran, L.C. Hsieh, R.L. Walter, M.J. Mekel, A. Evdokimov, and M.J. Janusz The development of 2-benzimidazole substituted pyrimidine based inhibitors of lymphocyte specific kinase (Lck) Bioorg. Med. Chem. Lett. 16 2006 5973 5977 (Pubitemid 44667817)
51. M.W. Martin, J. Newcomb, J.J. Nunes, C. Boucher, L. Chai, L.F. Epstein, T. Faust, S. Flores, P. Gallant, A. Gore, Y. Gu, F. Hsieh, X. Huang, J.L. Kim, S. Middleton, K. Morgenstern, A. Oliveira-dos-Santos, V.F. Patel, D. Powers, P. Rose, Y. Tudor, S.M. Turci, A.A. Welcher, D. Zack, H. Zhao, L. Zhu, X. Zhu, C. Ghiron, M. Ermann, D. Johnston, and C.G. Saluste Structure-based design of novel 2-amino-6-phenyl-pyrimido[5′,4′:5,6]pyrimido[1,2-a]benzimidazol- 5(6H)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR and in vivo anti-inflammatory activity J. Med. Chem. 51 6 2008 1637 1648 (Pubitemid 351438847)
52. J.A. Hunt, R.T. Beresis, J.L. Goulet, M.A. Holmes, X.J. Hong, E. Kovacs, S.G. Mills, R.D. Ruzek, F. Wong, J.D. Hermes, Y. Park, S.P. Salowe, L.M. Sonatore, L. Wu, A. Woods, D.M. Zaller, and P.J. Sinclair Disubstituted pyrimidines as Lck inhibitors Bioorg. Med. Chem. Lett. 19 2009 5440 5443
53. Y. Shen, R. Boivin, N. Yoneda, H. Du, S. Schiller, T. Matsushima, M. Goto, H. Shirota, F. Gusovsky, C. Lemelin, Y. Jiang, Z. Zhang, R. Pelletier, M. Ikemori-Kawada, Y. Kawakami, A. Inoue, M. Schnaderbeck, and Y. Wang Discovery of anti-inflammatory clinical candidate E6201, inspired from resorcylic lactone LL-Z1640-2, III Bioorg. Med. Chem. Lett. 20 10 2010 3155 3157
54. J.F. Evans, A.D. Ferguson, R.T. Mosley, and J.H. Hutchinson What's all the FLAP about? 5-lipoxygenase-activating protein inhibitors for inflammatory diseases Trends Pharmacol. Sci. 29 2 2008 72 78
55. J.H. Hutchinson, Y. Li, J.M. Arruda, C. Baccei, G. Bain, C. Chapman, L. Correa, J. Darlington, C.D. King, C. Lee, D. Lorrain, P. Prodanovich, H. Rong, A. Santini, N. Stock, P. Prasit, and J.F. Evans 5-Lipoxygenase-activating protein inhibitors: development of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy- pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2, 2-dimethyl-propionic acid (AM103) J. Med. Chem. 52 19 2009 5803 5815
56. N. Stock, C. Baccei, G. Bain, A. Broadhead, C. Chapman, J. Darlington, C. King, C. Lee, Y. Li, D.S. Lorrain, P. Prodanovich, H. Rong, A. Santini, J. Zunic, J.F. Evans, J.H. Hutchinson, and P. Prasit 5-Lipoxygenase-activating protein inhibitors. Part 2: 3-{5-((S)-1-Acetyl-2,3-dihydro-1H-indol-2-ylmethoxy) -3-tert-butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-1H-indol-2-yl}-2, 2-dimethyl-propionic acid (AM679)-a potent FLAP inhibitor Bioorg. Med. Chem. Lett. 20 1 2010 213 217
57. N. Stock, C. Baccei, G. Bain, C. Chapman, L. Correa, J. Darlington, C. King, C. Lee, D.S. Lorrain, P. Prodanovich, A. Santini, K. Schaab, J.F. Evans, J.H. Hutchinson, and P. Prasit 5-Lipoxygenase-activating protein inhibitors. Part 3: 3-{3-tert-butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-5-(5- methyl-pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropionic acid (AM643)-a potent FLAP inhibitor suitable for topical administration Bioorg. Med. Chem. Lett. 20 15 2010 4598 4601
58. N.S. Stock, G. Bain, J. Zunic, Y. Li, J. Ziff, J. Roppe, A. Santini, J. Darlington, P. Prodanovich, C.D. King, C. Baccei, C. Lee, H. Rong, C. Chapman, A. Broadhead, D. Lorrain, L. Correa, J.H. Hutchinson, J.F. Evans, and P. Prasit 5-Lipoxygenase-activating protein (FLAP) inhibitors. Part 4: development of 3-[3-tert-butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2- ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropionic acid (AM803), a potent, oral, once daily FLAP inhibitor J. Med. Chem. 54 23 2011 8013 8029
59. E. Banoglu, B. Caliskan, S. Luderer, G. Eren, Y. Ozkan, W. Altenhofen, C. Weinigel, D. Barz, J. Gerstmeier, C. Pergola, and O. Werz Identification of novel benzimidazole derivatives as inhibitors of leukotriene biosynthesis by virtual screening targeting 5-lipoxygenase-activating protein (FLAP) Bioorg. Med. Chem. 20 2012 3728 3741
60. M. Gaba, D. Singh, S. Singh, V. Sharma, and P. Gaba Synthesis and pharmacological evaluation of novel 5-substituted-1-(phenylsulfonyl)-2- methylbenzimidazole derivatives as anti-inflammatory and analgesic agents Eur. J. Med. Chem. 45 6 2010 2245 2249
61. G.M. Rao, Y.N. Reddy, and B.V. Kumar Evaluation of analgesic and anti-inflammatory activities of N-mannich bases of substituted 2-mercapto-1H-benzimidazoles Int. J. Appl. Biol. Pharm. Technol. 4 1 2013 38 46
62. A. Ravindernath, and M.S. Reddy Synthesis and evaluation of anti-inflammatory, antioxidant and antimicrobial activities of densely functionalized novel benzo-[d]-imidazolyl tetrahydropyridine carboxylates Arab. J. Chem. 2013 in press
63. S. Kankala, R.K. Kankala, P. Gundepaka, N. Thota, S. Nerella, M.R. Gangula, H. Guguloth, M. Kagga, R. Vadde, and C.S. Vasam Regioselective synthesis of isoxazole-mercapto benzimidazole hybrids and their in vivo analgesic and anti-inflammatory activity studies Bioorg. Med. Chem. Lett. 23 5 2013 1306 1309
64. B.G. Mohamed, A.M. Abdel-Alim, and M.A. Hussein Synthesis of 1-acyl-2-alkylthio-1,2,4-triazolobenzimidazoles with antifungal, anti-inflammatory and analgesic effects Acta Pharm. Res. 56 2006 31 48 (Pubitemid 43253971)
65. G. Mariappan, N.R. Bhuyan, P. Kumar, D. Kumar, and K. Murali Synthesis and biological evaluation of Mannich bases of benzimidazole derivatives Ind. J. Chem. 50B 2011 1216 1219
66. K.C.S. Achar, K.M. Hosamani, and H.R. Seetharamareddy In-vivo analgesic and anti-inflammatory activities of newly synthesized benzimidazole derivatives Eur. J. Med. Chem. 45 5 2010 2048 2054
67. S. Rajasekaran, G. Rao, and A. Chatterjee Synthesis, anti-inflammatory and anti-oxidant activity of some substituted benzimidazole derivatives Int. J. Drug Dev. Res. 4 3 2012 303 309
68. S.M. Sondhi, R. Rani, J. Singh, P. Roy, S.K. Agrawal, and A.K. Saxena Solvent free synthesis, anti-inflammatory and anticancer activity evaluation of tricyclic and tetracyclic benzimidazole derivatives Bioorg. Med. Chem. Lett. 20 7 2010 2306 2310
69. S.M. Sondhi, S. Rajvanshi, M. Johar, N. Bharti, A. Azam, and A.K. Singh Anti-inflammatory, analgesic and antiamoebic activity evaluation of pyrimido[1,6-a]benzimidazole derivatives synthesized by the reaction of ketoisothiocyanates with mono and diamines Eur. J. Med. Chem. 37 10 2002 835 843 (Pubitemid 35346544)
70. K. Taniguchi, S. Shigenaga, T. Ogahara, T. Fujitsu, and M. Matsuo Synthesis and anti- inflammatory and analgesic properties of 2-amino-1H-benzimidazole and 1,2-dihydro-2- iminocycloheptimidazole derivatives Chem. Pharm. Bull. 41 2 1993 301 309 (Pubitemid 23128192)
71. A.O.H. El-Nezhawy, S.T. Gaballah, M.A.A. Radwan, A.R. Baiuomy, and O.M.E. Abdel-Salam Structure-based design of benzimidazole sugar conjugates: synthesis, SAR and in vivo anti-inflammatory and analgesic activities Med. Chem. 5 2009 558 569
72. A.O.H. El-Nezhawy, A.R. Biuomy, F.S. Hassan, A.K. Ismaiel, and H.A. Omar Design, synthesis and pharmacological evaluation of omeprazole-like agents with anti-inflammatory activity Bioorg. Med. Chem. 21 7 2013 1661 1670
73. Y. Bansal, and O. Silakari Synthesis and pharmacological evaluation of polyfunctional benzimidazole-NSAID chimeric molecules combining antiinflammatory, immunomodulatory and antioxidant activities Arch. Pharm. Res. 2013 in press
74. A.F. Mohammed, S.G. Abdel-Moty, M.A. Hussein, and A.M. Abdel-Alim Design, synthesis and molecular docking of some new 1,2,4-triazolobenzimidazol-3-yl acetohydrazide derivatives with anti-inflammatory analgesic activities Arch. Pharm. Res. 36 12 2013 1465 1479